suma/phosphatase

BACKGROUND OF THE INVENTION Phytases are myo-inositol hexakisphosphate phosphohydrolases that catalyze the stepwise removal of inorganic orthophosphate from phytate (myo-inositol hexakisphosphate) (1). There are two types of phytases. One is called 3-phytase (EC.3.1.3.8) which initiates the removal

BACKGROUND OF THE INVENTION The present invention relates to nucleic acid sequences and methods useful for producing recombinant glucose-6-phosphatase (G-6-Pase). In addition, the present invention relates to specific mutations in the gene encoding human G-6-Pase and methods for detecting the

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims, under 35 U.S.C. .sctn. 119, the priority of Korean Patent Application No. 10-2016-0162235, filed on Nov. 30, 2016, and Korean Patent Application No. 10-2017-0044300, filed on Apr. 5, 2017, in the Korean Intellectual Property Office,

FIELD OF THE INVENTION The invention relates to the field of biotechnology. In particular, the invention relates to a novel polypeptide, phosphatidic acid phosphatase 29.81, and a polynucleotide sequence encoding said polypeptide. The invention also relates to the method for the preparation and use

CROSS-REFERENCE TO RELATED APPLICATIONS This application is filed under the provisions of 35 U.S.C. .sctn.371 and claims the priority of International Patent Application No. PCT/KR2010/003675 filed on 8 Jun. 2010 entitled "METAGENOME-DERIVED ALKALINE PHOSPHATASE" in the name of Seung Goo LEE, et

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the DNA coding for phosphoserine phosphatase of coryneform bacteria. The DNA may be utilized for microbiologic industry, such as breeding L-serine producing coryneform bacteria. 2. Description of the Related

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the DNA coding for phosphoserine phosphatase of coryneform bacteria. The DNA may be utilized for microbiologic industry, such as breeding L-serine producing coryneform bacteria. 2. Description of the Related

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the DNA coding for phosphoserine phosphatase of coryneform bacteria. The DNA may be utilized for microbiologic industry, such as breeding L-serine producing coryneform bacteria. 2. Description of the Related

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Oct. 18, 2010, is named 65353US5.txt and is 28,307 bytes in size. Each of the applications

BACKGROUND OF THE INVENTION It has been previously established (U.S. Patent App. Pub. No. 20050066381) that Protein Kinase C alpha ("PKC-.alpha.") activity is increased in the pathological state of heart failure. Phosphatase Inhibitor Protein-1 (I-1) is a key regulator of cardiac contractility. I-1

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to a decoy peptide or polypeptide of phospholamban capable of inhibiting the protein phosphatase 1-mediated dephosphorylation of phospholamban and its use as well as a method for preparing the decoy peptide or

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to a decoy peptide or polypeptide of phospholamban capable of inhibiting the protein phosphatase 1-mediated dephosphorylation of phospholamban and its use as well as a method for preparing the decoy peptide or

This application is the National Stage of Application No. PCT/EP2006/046543, filed on Dec. 6, 2006, which claims benefit under 35 U.S.C. .sctn.119(a-d) of U.S. Provisional Application No. 60/748,491, filed Dec. 8, 2005, the contents of which are incorporated herein by reference in their

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to a method for administering protein phosphatase inhibitors to an individual to diminish myocardial infarction and minimize cell injury or death in ischemic tissue. Specifically, the present invention

FIELD OF THE INVENTION The invention relates to monitoring of phosphorylation or dephosphorylation of a protein. BACKGROUND OF THE INVENTION The post-translational modification of proteins has been known for over 40 years and since then has become a ubiquitous feature of protein structure. The